Novartis and QTL win innovation award
Novartis Ophthalmics and QLT Inc. were awarded with the Helen Keller Prize for Innovation in Eye Care for their development of Visudyne (verteporfin for injection) therapy.
Novartis Ophthalmics and QLT Inc. were awarded with the Helen Keller Prize for Innovation in Eye Care for their development of Visudyne (verteporfin for injection) therapy.